Industries > Pharma > Generic Drugs: World Market 2014-2024
Back to Pharma Reports

Generic Drugs: World Market 2014-2024

& Future Prospects for Leading Companies

PUBLISHED: 20 February 2014
PAGES: 238
PRODUCT CODE:
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: N/A Categories: ,

Generic drugs – new study showing you trends, R&D progress, and predicted revenues

Where's the generic drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 238 page report provides 154 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. As pharma patents expire, much opportunity remains.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of three exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
– Professor Joshua P. Cohen, PhD, Research Assistant Professor, Tufts Center for the Study of Drug Development, Boston, Massachusetts, USA
– David Gaugh, R.Ph., Senior Vice President of Science and Regulatory Affairs, Generic Pharmaceutical Association, Washington DC, USA
– Pieter Dylst, PhD, Post-doctoral Researcher, Katholieke Universiteit Leuven

What are the prospects in the leading regions and countries?

In addition to analyses of the overall world market, you will discover individual revenue forecasts for 14 leading national markets to 2024:
•    US
•    China
•    Japan
•    Germany
•    India
•    France
•    UK
•    Russia
•    Italy
•    Brazil
•    Mexico
•    South Korea
•    Turkey
•    Spain
•    Row

There will be growth in established pharma markets and in developing countries. Our analyses show that Japan, India, Mexico and Brazil, in particular, will continue to achieve high revenue growth to 2024. Events and progress worldwide will influence the market

Leading companies and potential for market growth

Overall world revenue for generic medicines will reach $199.2bn in 2014, our report reveals We predict strong revenue growth from 2014 to 2024. Rising demand for prescription drugs, expanding healthcare coverage, payers favouring generics and changes to prescribing will increase sales to 2024.

Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:
•    Novartis
•    Teva
•    Actavis
•    Mylan
•    Abbott
•    Pfizer
•    Fresenius Kabi
•    Hospira
•    Aspen
•    Sanofi

A company profile gives you the following information:
•    Revenue forecast for generic drugs from 2014 to 2024
•    Discussion of a company's activities and outlook
•    Recent financial results
•    Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the generics industry?

Our new report discusses issues and events affecting the generic drugs market. You will find discussions, including qualitative analyses:
•    Improving regulatory processes
•    Increasing demand for generic medicines due to demographic trends
•    High predicted growth in emerging markets
•    Price controls by governments
•    Decline in pipeline of drugs nearing patent expiry
•    Consolidation among pharmacies and healthcare payers
•    Increasing perception of generic drugs as unsafe and low quality

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Generic Drugs: World Market 2014-2024 & Future Prospects for Leading Companies report helps you

In summary, our 238 page report gives you the following knowledge:
•    Revenues forecast to 2024 for the overall world market – discover the industry's prospects, finding promising places for investments and revenues
•    Revenue forecasts to 2024 for the leading 14 national markets – US, China, Japan, India, Germany, France, UK, Russia, Brazil, Mexico, Italy, South Korea, Turkey, Spain and RoW
•    Assessment of 10 leading companies – hear about products, results and strategies inc. revenue forecasts for generic drugs to 2024
•    IP policy and other regulations – see what affects market access and entry
•    Patent expiry – find prominent drug brands facing generic competition
•    Trends of prescribers and healthcare payers – assess developments
•    Discussion of what stimulates and restrains companies and the market
•    Prospects for established companies and those seeking to enter the market
•    View opinions from our survey, seeing exclusive interviews with authorities

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the generic drugs market and leading companies. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs: World Market 2014-2024


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs: World Market 2014-2024


Connect with us

Visiongain Pharma

Visiongain Pharma

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories